Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
RSS icon
Thumbnail

Scale AI announces $3.4M investment in COVID-19 research

Scale AI is funding eight research projects focused on helping Canada respond to the ongoing COVID-19 pandemic, an investment that adds up to $3.4 million.

Thumbnail

AI-powered test spots early signs of glaucoma progression

The test may also have a second important use—improving the treatment of COVID-19 patients.

Thumbnail

All-new AI tool lightens the workload for researchers studying COVID-19

An unlikely team at Berkeley Lab has created a text-mining tool that may help scientists of all disciplines tame and tap the presently blinding blizzard of COVID-19 papers.

Thumbnail

AI helps radiologists distinguish COVID-19 from conventional pneumonia

A new AI model can help radiologists distinguish COVID-19 from non-COVID 19 pneumonia when reading chest CT examinations.

Thumbnail

New blockchain system from IBM eyes COVID-19 supply shortages

IBM has launched a blockchain-based network for healthcare organizations and government agencies looking to quickly find and hire alternative supply-chain sources during the public-health crisis set off by the COVID-19 outbreak.

Thumbnail

Healthcare AI a ‘potent tool’ in the global pandemic project

For champions of AI in healthcare, the COVID-19 crisis affords an unignorable opportunity to trumpet the technology’s current contributions while directing attention to its potential for helping fight public-health crises to come.

Thumbnail

New AI model could help brain cancer patients avoid biopsies

Glioma patients typically need a biopsy so physicians can make a treatment decision, but researchers have developed a new AI algorithm that could make such biopsies unnecessary. 

Thumbnail

Can AI, robotics help ID asymptomatic carriers of COVID-19?

Researchers in Israel are working to develop a new AI-powered COVID-19 test—and they think it could be especially effective at detecting individuals who carry the virus without showing any symptoms.

Displaying 305 - 312 of 3584

Around the web

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup